Select
Home
About Us
Company Overview
Management Team
Board of Directors
Scientific Advisory Board
Corporate Governance
Development
Assets in Development
Deoxymab 3E10
PAT SC1
Investors
Analysts Reports
Annual Reports
Financial Reports 2019
Financial Reports 2018
Financial Reports 2017
Financial Reports 2016
News & Media
Market Announcements 2019
Market Announcements 2018
Market Announcements 2017
Newsletters
In the Media
Media Contact
Contact
ASX: PAB
LATEST NEWS
23 August 2019
Annual Report 2019
19 August 2019
Patrys Presents at Leading Brain Metastases Conference
24 July 2019
Updated Investor Presentation and Attendance at Bioshares
DEOXYMAB 3E10 INTRODUCTION
DEOXYMAB 3E10 PLATFORM
